Retail

FDA upgrades Gregory's cookie recall to Class I over undeclared peanuts

Gregory's Foods' cookie dough recall has been upgraded to Class I by the FDA, the agency's highest risk category, after undeclared peanuts were traced to a misfill. The move underscores the allergen risk for peanut-allergic consumers and signals intensified regulatory scrutiny for the four-state rollout across Minnesota, Nebraska, North Dakota and Wisconsin. Consumers should not eat the product and should return it to retailers for a full refund.

📅 January 23, 2026
⏱️ 2 min read
FDA upgrades Gregory's cookie recall to Class I over undeclared peanuts

Key Takeaways

  • The FDA upgraded the recall to Class I on January 22, 2026, signaling a high-severity allergen risk.
  • Mispacked Monster Cookie Dough (peanuts) contaminated White Chocolate Macadamia Nut dough, causing undeclared peanut exposure.
  • Recall covers more than 300 cases (six bags per case) across Minnesota, Nebraska, North Dakota and Wisconsin, with a best-by date of December 6, 2026.
  • Consumers should not eat the product and should return it to retailers for a full refund; the issue was isolated to one production day and has been corrected.

People Involved

  • No specific individuals mentioned

Entities Involved

  • Gregory's FoodsCookie-dough producer behind the recall
  • Monster Cookie DoughPeanut-containing dough brand mispackaged into Gregory's White Chocolate Macadamia Nut dough
  • FDAU.S. Food and Drug Administration; regulator issuing recall upgrade

MarketMoodz Analysis

For investors and retailers, the Class I upgrade amplifies regulatory risk and potential reputational damage for Gregory's Foods, prompting recalls-and-remediation steps across the distribution chain. The four-state geographic reach (Minnesota, Nebraska, North Dakota and Wisconsin) concentrates exposure and raises the stakes for stock-keeping units and retail partners.

Historically, Class I recalls carry meaningful consumer-impact signals and can pressure underlying brand expectations, particularly for allergen-related products. The note that the issue was isolated to a single production day supports a containment narrative, but execution risk remains as distributors verify stock and retailers clear shelves.

What to watch next: the official recall notice for precise production-day data and packaging guidance, any expansion of affected lots, and Gregory's Foods' remediation plan and potential impact on sales and margins. Regulators will likely maintain heightened vigilance on allergen controls and supplier QA.

Source: Original Article

Get AI-Powered Market Insights

Stay ahead of market-moving events with our real-time analysis and stock ratings.

Start Your Free Trial